Science Applications International (SAIC) has landed on investor radars after reporting second quarter and six month results with higher sales and earnings guidance raised for fiscal 2027, shifting expectations for the business.
Against that backdrop, Science Applications International has been in a steady uptrend, with the share price returning 26.01% year to date and 11.66% over the past 90 days. The 1 year total shareholder return of 25.87% points to momentum that has been building rather than fading around the recent earnings, raised 2027 guidance and continued buybacks.
Scan other defense and government IT contractors showing similar momentum and capital return stories through our curated list of list of solid balance sheet and fundamentals (24 results).
Science Applications International now trades with fresh earnings, higher 2027 revenue guidance and ongoing buybacks in the rear‑view mirror. Are you watching a sentiment swing, or a price that better reflects the underlying business as it is today?
The most followed narrative on Science Applications International pegs fair value at $119.24 versus a last close of $127.55, so the story assumes a richer price than that model implies while still leaning on management’s own guidance upgrades to justify the gap.
Guidance was raised. June explicitly deferred to September for a revenue guidance revision, with the qualitative nudge that performance would land "closer to the midpoint, maybe a little bit ahead." August delivered: revenue guidance raised by 2% to a $7.25 billion midpoint, EBITDA guidance raised by 4% at the midpoint to an implied 10.3%-10.5% margin range, and EPS revised upward. The $600 million-plus free cash flow target was maintained. June's "year of commitment" framing, setting targets management is confident it can achieve, was reiterated word for word by Reagan in August.
Want to see how this raised guidance flows into that valuation gap for Science Applications International? The key assumptions sit in margins, on contract growth, and capital deployment. The full narrative connects those pieces into one cohesive pricing story.
Result: Fair Value of $119.24 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the Science Applications International story could be disrupted if book-to-bill remains below 1.0 or if the December portfolio review falls short of expectations.
Find out about the key risks to this Science Applications International narrative.
Science Applications International screens very differently when you look at simple market ratios. The shares trade on a P/E of 14.1x, which sits well below both the US Professional Services industry at 22.6x and peer average at 22.5x. The fair ratio of 17.5x suggests the market could shift closer to that level over time, which points to a very different risk and reward profile than a narrative calling the stock 7% overvalued. Which lens do you trust more when prices move fast?
To see how this valuation gap plays out against peers and that fair ratio, take a closer look at the detailed breakdown in our ratio-based review of Science Applications International, then compare it with your own expectations for growth and risk, See what the numbers say about this price — find out in our valuation breakdown.
Mixed messages in the Science Applications International story so far. If you want to move fast and build your own conviction, compare the upside and downside case through the 3 key rewards and 1 important warning sign
If Science Applications International has sharpened your focus, do not stop here. Broadening your watchlist can help you spot opportunities you might otherwise miss.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com